Immediate Impact
1 from Science/Nature 60 standout
Citing Papers
Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
2022 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Works of R. Guévin being referenced
Phase III Trial Comparing Granulocyte Colony-Stimulating Factor to Leridistim in the Prevention of Neutropenic Complications in Breast Cancer Patients Treated with Docetaxel/Doxorubicin/Cyclophosphamide: Results of the BCIRG 004 Trial
2002
Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy.
1997
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| R. Guévin | 99 | 41 | 122 | 67 | 10 | 261 | |
| James Trotter | 128 | 21 | 123 | 80 | 13 | 302 | |
| Wei Shu Wang | 188 | 120 | 41 | 35 | 12 | 326 | |
| Babak N. Kalantari | 86 | 31 | 168 | 45 | 10 | 265 | |
| Penny Shaw | 55 | 38 | 48 | 26 | 11 | 306 | |
| S. Luzi Fedeli | 122 | 29 | 42 | 38 | 11 | 304 | |
| Michèle D. Bishop | 71 | 68 | 148 | 17 | 7 | 290 | |
| S. H. M. Zaidi | 138 | 58 | 65 | 20 | 10 | 325 | |
| Mary Beauchamp | 41 | 155 | 31 | 34 | 10 | 331 | |
| H. Wolf | 99 | 26 | 68 | 38 | 14 | 235 | |
| Gennaro De Rosa | 98 | 50 | 25 | 23 | 14 | 295 |
All Works
Loading papers...